Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study
Although the overall survival has not yet been reached in this young population, our reported median PFS of only 45 months highlights the urgent need to develop innovative treatments to induce more profound and durable responses.
Authors
- Christopher P. Venner (ORCID: https://orcid.org/0000-0003-4701-4285)
- Jean Roy (ORCID: https://orcid.org/0000-0002-7716-6864)
- Richard LeBlanc (ORCID: https://orcid.org/0000-0001-9990-2183)
- Arleigh McCurdy (ORCID: https://orcid.org/0000-0002-8809-4368)
- Muhammad Aslam (ORCID: https://orcid.org/0000-0003-3208-9858)
- Rayan Kaedbey (ORCID: https://orcid.org/0000-0002-8556-4926)
- Darrell White (ORCID: https://orcid.org/0000-0002-1341-4160)
- Debra Bergstrom (ORCID: https://orcid.org/0000-0002-4073-5453)
- Martha Louzada (ORCID: https://orcid.org/0000-0002-4531-7859)
- Hira S. Mian (ORCID: https://orcid.org/0000-0003-1584-1067)
- Mégane Tanguay (ORCID: https://orcid.org/0000-0001-9498-0609)
- Tony Reiman (ORCID: https://orcid.org/0000-0002-2706-8764)
- Michael P. Chu (ORCID: https://orcid.org/0000-0002-2826-3342)
- Julie Stakiw (ORCID: https://orcid.org/0009-0002-4844-4121)
- Michaël Sébag (ORCID: https://orcid.org/0000-0002-9013-2941)
- Engin Gul (ORCID: https://orcid.org/0000-0002-3922-3215)
- Jiandong Su (ORCID: https://orcid.org/0000-0002-4303-9699)
- Kevin Song (ORCID: https://orcid.org/0000-0003-0786-7961)
- Rami Kotb
- Donna Reece
- Victor H. Jimenez‐Zepada
Institutions
- BC Cancer Agency (CA)
- Dalhousie University (CA)
- Memorial University of Newfoundland (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- Juravinski Cancer Centre (CA)
- Queen Elizabeth II Health Sciences Centre (CA)
- Saint John Regional Hospital (CA)
- Ottawa Hospital (CA)
- Jewish General Hospital (CA)
- Princess Margaret Cancer Centre (CA)
- Vancouver General Hospital (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- University of Saskatchewan (CA)
- CancerCare Manitoba (CA)
- Saskatchewan Cancer Agency (CA)
- Canadian Apheresis Group (CA)
- Ottawa Regional Cancer Foundation (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/cam4.70332
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- Celgene
- Hamilton Health Sciences
- Regeneron Pharmaceuticals
- Université de Montréal
- Hamilton Health Sciences Foundation